Canola oil protects against colon cancer, study finds
April 13, 2011 in Cancer(PhysOrg.com) -- A first-of-its-kind study of canola oil finds that it reduces the size and incidence of colon tumors in laboratory animals, a South Dakota State University scientist says.
The research suggests using canola oil in household cooking may protect against colon cancer development.
Distinguished professor Chandradhar Dwivedi, head of SDSUs Department of Pharmaceutical Sciences, led the study. He and his colleagues published their journal article on the topic, Chemopreventive Effects of Dietary Canola Oil on Colon Cancer Development, in the February 2011 issue of the journal Nutrition and Cancer.
This is the first time anyone has done work on the effect of canola oil in animals on colon cancer prevention. Canola oil was able to reduce the incidence of colon cancer in animals almost to one-third, Dwivedi said.
The study showed that canola oil inhibited the average number of tumors per rat by 58 percent compared to one of the other two control diets in the experiment, and inhibited the size of the tumors that occurred by 90 percent.
Colon cancer causes more deaths than any other form of cancer in men and women in the United States. American Cancer Society statistics say there were about 102,900 cases of colon and 39,670 cases of rectal cancer in 2010, resulting in an estimated 51,370 deaths.
Dwivedi said professor Padmanaban Krishnan in SDSUs Department of Health and Nutritional Sciences suggested the study of canola oils potential in protecting against colon cancer because Dwivedi had already led similar studies looking at the cancer-fighting properties of flaxseed meal and flaxseed oil. Krishnan was one of the collaborators in the study. The project was carried out under the auspices of grants from North Central Canola Research, North Dakota State University, and National Canola Growers. Value addition of oilseeds is also supported by the South Dakota Agricultural Experiment Station.
Flaxseed oil has a much higher level of Omega-3 fatty acids that are partly responsible for the health benefits more than 50 percent compared to about 10 percent in canola oil but canola oil may be easier to include in a typical American diet.
The advantage of canola is it can be used for day to day cooking, frying and anything else, in contrast to the flax, Dwivedi said. You could not use flax oil for frying. If people start using canola oil, replacing other oils with canola oil, it gives them the advantage of including Omega-3s in their diet.
Dwivedi adds that studies have indicated that if consumers use canola as household cooking oil, it could push their ratio of Omega-6 to Omega-3 fatty acids to about 3 to 1. Thats very desirable. Humans need Omega-6 fatty acids, too, but they typically consume way too much of them in countries such as the United States.
It should be less than 4 to 1. But in a typical American diet, when we use other oil and butter, our ratio is 10 to 1 or higher. We consume a lot more Omega-6 than Omega-3 fatty acids, Dwivedi said. So anything we could do to bring that ratio more in favor of Omega-3 is always good.
The research builds on earlier studies by Dwivedi and his colleagues suggesting that Omega-3 fatty acids have a chemopreventive effect by inhibiting an enzyme called cyclooxygenase and reducing the synthesis of arachidonic acid, both of which are associated with inflammation.
-
Canola-type rapeseed oil reduces the level of fibrinogen, a cause of thrombosis and inflammation
Nov 08, 2010 |
not rated yet |
0
-
Researchers find that fish oil boosts responses to breast cancer drug tamoxifen
Apr 06, 2011 |
not rated yet |
0
-
It's no fish tale: Omega-3 fatty acids prevent medical complications of obesity
Feb 12, 2009 |
not rated yet |
0
-
Fish oil's fatty acids provide surprising benefits to lung cancer patients
Mar 07, 2011 |
not rated yet |
0
-
Altering Fatty Acid Levels in Diet May Reduce Prostate Cancer Growth Rate
Aug 01, 2006 |
not rated yet |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (3) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (41) |
45
-
Your brain on dye: Imaging neuronal voltage with fluorescent sensors and molecular wires
Feb 24, 2012 |
4.9 / 5 (9) |
0
-
Understanding the mechanisms of disease .
May 14, 2012
-
Short burst of hypersensitivity disorder?
May 13, 2012
-
Copper aspirinate
May 12, 2012
-
Ultraviolet rays and diseases
May 12, 2012
-
Article: Robot Reveals the Inner Workings of Brain Cells
May 11, 2012
-
Recommend to me the textbook on an inflammation, please
May 08, 2012
- More from Physics Forums - Medical Sciences
More news stories
Hormone-depleting drug shows promise against localized high-risk prostate tumors
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, ...
Cancer
4 hours ago |
5 / 5 (1) |
0
Experimental agent may help older people with chronic leukemia
The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial.
Cancer
4 hours ago |
not rated yet |
0
Phase I study of temsirolimus, capecitabine proves safe; positive survival trend seen
A phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests the two agents can be given safely to patients. In addition, the Georgetown Lombardi Comprehensive ...
Cancer
4 hours ago |
5 / 5 (1) |
0
Revised glioblastoma classification should improve patient care
Radiation oncology researchers have revised the system used by doctors since the 1990s to determine the prognosis of people with glioblastoma, which is the most devastating of malignant brain tumors.
Cancer
4 hours ago |
not rated yet |
0
Study combines lapatinib with cetuximab to overcome resistance in EGFR-driven tumors
Targeted therapies have been studied for years, but recent laboratory research is providing robust clues about drugs that might work better in combination, particularly in treating cancers that have become resistant to therapy. ...
Cancer
4 hours ago |
not rated yet |
0
Paralyzed individuals control robotic arms to reach and grasp using brain computer interface (w/ Video)
In an ongoing clinical trial, a paralyzed woman was able to reach for and sip from a drink on her own for the first time in nearly 15 years by using her thoughts to direct a robotic arm. The ...
Zebrafish study isolates gene related to autism, schizophrenia and obesity
What can a fish tell us about human brain development? Researchers at Duke University Medical Center transplanted a set of human genes into a zebrafish and then used it to identify genes responsible for head ...
ApoE4 Alzheimer's gene causes brain's blood vessels to leak, die
Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer's disease, but the gene's role in the disease has been unclear. Now, researchers funded by the National ...
Landscape of cancer genes and mutational processes in breast cancer
In a study published today in Nature, researchers describe nine new genes that drive the development of breast cancer. This takes the tally of all genes associated with breast cancer development to 40.
Experts say psychiatry's diagnostic manual needs overhaul
The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form, according to an essay by two ...
Study finds common antibiotic azithromycin carries heart risk
Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a "Z-pack." The study found a 2.5-fold higher risk of death from cardiovascular death in the first five ...